Levels of N-terminal-pro-brain natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 461-466

  Pérez Piaya, María Rosa ^a   Abarca, Elena ^a   Soler, Virginia ^a   Coca, Ana ^a   Cruz, Marta ^a   Villagrá, Fernando ^a   Giannivelli, Silvina ^a   Asensio, Ángel ^b  

^a Hospital Madrid Monteprincipe   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Brain natriuretic peptides; Pediatric open heart surgery; Postoperative prognostic biomarker

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEMOFILTRATION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PURIFICATION; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; LINEAR MODELS; LOGISTIC MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952328438     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.245803     Document Type: Article

References (25)

1. Hall C. NT-ProBNP: the mechanism behind the marker. J Card Fail 2005;11(Suppl):S81-S83.
2. Gessler P, Walter K, Bernahard S, Valentin R, Arnold VE. Prognosis value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 2006; 148:372-376.
3. Nessmisth MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 2005;96:1445-1448.
4. Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénissiano J. Plasma brain natriuretic peptide and cardiac troponine I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006;34:995-1000.
5. Sinha AM, Breithardt OA, Schmid M, Stellbrink C. Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 2005;53:138-143.
6. Kirchhoff WCh, Gradaus R, Stypmann J, Deng MC, Tian TD, Scheld HH, Breithardt G, Brisse BH. Vasoactive peptides during long-term followup patients after cardiac transplantation. J Heart Lung Transplant 2004; 284-288.
7. Kubanek M, Málek I, Kautzner J, Kautzner J, Hegarová M, Wiendl M, Lupínek K, Lánská V. The value of B-type natriuretic peptide and bigendothelin 1 for detection of severe pulmonary hypertension in heart transplant candidates. Eur J Heart Fail 2005;7:1149-1155.
8. Lindblade CL, Chun DS, Darragh RK, Caldwell RL, Murphy DJ, Schamberger MS. Value of plasma B-Type as a marker in pediatric heart transplant recipients. Am J Cardiol 2005;95:909-911.
9. Mir TS, Mahron S, Laer S, Eisetl M, Grollmus O, Weil J. Plasma concentrations of N terminal pro-brain natriuretic in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002;110:e76.
10. Nir A, Nasser N, Perles Z, Rein AJJT. N-terminal B-natriuretic peptide and B-Type natriuretic peptide levels in children with history of dilated cardiomyopathy or myocarditis. Cardiol Young 2004;14(Suppl):36.
11. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005;11(5 Suppl):S76-S80.
12. Kunni Y, Kamada M, Ohtsuki S, Araki T, kataoka K, Kageyama M. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003;57:191-197.
13. Soda K, Matsumura M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003; 45:249-254.
14. Tulevski H, Dodge-Khatami A, Groenink M, van der Wall EE, Romkes H, Mulder BJ. Right ventricular function in congenital cardiac disease: noninvasive quantitative parameters for clinical follow-up. Cardiol Young 2003;13:397-403.
15. Gerber H, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-1890.
16. Walsh R, Boyer C, LaCorte J, Parnell V, Sison C, Chowdhury D, Ojamaa K. N-terminal B-type natriuretic peptide levels in pediatrics with congestive heart failure undergoing cardiac surgery. J Thorac Cardiovasc Surg 2008;135:98-105.
17. Carmona F, Manso PH, Vicente WVA, Castro M, Carlotti APCP. Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponine. Cytokine 2008;42:317-324.
18. Mir TS, Haun C, Lilje C, Läer S, Weil J. Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponine in children with congenital heart disease following openheart surgery. Pediatr Cardiol 2006;27:20-216.
19. Jenkins K, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002;123:110-118.
20. Ricci Z, Morelli S, Ronco C, Polito A, Stazi GV, Giorni C, Di Chiara L, Picardo S. Inotropic support and peritoneal dialysis adequacy in neonate after cardiac surgery. Interact CardioVasc Thorac Surg 2008;7:116-120.
21. Shore S, Nelson D, Peartl J, Manning PB, Wong H, Shanley TP, Keiser T, Schwartz SM. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically infants with congenital heart disease. Am J Cardiol 2001;88:591-594.
22. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006;366:304-308.
23. Hopkins WF, Chen Z, Fukagawa NK. Increases atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004;109:2872-2877.
24. Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta 2001;303;127-132.
25. Ricci Z, Garisto C, Morelli S, Di Chiara L, Ronco C, Picardo S. Brain natriuretic peptide is removed by continuous veno-venous hemofiltrationin pediatric patients. Interact CardioVasc Thorac Surg 2009;9:33-36.